title: Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies.
abstract: Sporadic Parkinson's disease (PD) is now interpreted as a complex nervous system disorder in which the projection neurons are predominantly damaged. Such an interpretation is based on mapping of Lewy body and Lewy neurite pathology. Symptoms of the human disease are much widespread, which span from pre-clinical non-motor symptoms and clinical motor symptoms to cognitive discrepancies often seen in advanced stages. Existing symptomatic treatments further complicate with overt drug-irresponsive symptoms. PD is better understood by assimilation of extranigral degenerative pathways with nigrostriatal degenerative mechanisms. The term 'extranigral' appeared first in the 1990s to more rigorously define the nigral pathology by process of elimination. However, as clinicians progressively identified PD symptoms unresponsive to the gold standard drug l-DOPA, definitions of PD symptoms were redefined. Non-motor symptoms prodromal to motor symptoms just as pre-clinical to clinical, and conjointly emerged the concept of nigral versus extranigral degeneration in PD. While nigrostriatal degeneration is responsible for the neurobiological substrates of extrapyramydal motor features, extranigral degeneration corroborates a vast majority of other changes in discrete central, peripheral, and enteric nervous system nuclei, which together account for global symptoms of the human disease. As an extranigral site, spinal cord degeneration has also been implicated in PD progression. Interconnected to the upper CNS structures with descending and ascending pathways, spinal neurons participate in movement and sensory circuits, controlling movement and reflexes. Several clinical and in vivo studies have demonstrated signs of parkinsonism-related degenerative processes in spinal cord, which led to recent consideration of spinal cord as an area of potential therapeutic target. In a nutshell, this review explores how the existing animal models can actually reflect the human disease in order to facilitate PD research. Evolution of extranigral degeneration studies has been succinctly revisited, followed by a survey on animal models in light of recent findings in clinical PD. Together, it may help to develop effective therapeutic strategies for PD.
authors: Department of Neurosciences, Medical University of South Carolina, Charleston, South Carolina, USA.
authors: Varduhi H
authors: VH
authors: Knaryan
authors: Supriti
authors: S
authors: Samantaray
authors: Charlene
authors: C
authors: Le Gal
authors: Swapan K
authors: SK
authors: Ray
authors: Naren L
authors: NL
authors: Banik
references: J Neural Transm (Vienna). 2008 Aug;115(8):1133-9
references: 18528630
references: Neuroscience. 2000;97(1):79-88
references: 10771341
references: Ital J Neurol Sci. 1990 Aug;11(4):367-72
references: 2246119
references: Parkinsonism Relat Disord. 2009 Dec;15 Suppl 4:S28-32
references: 20123553
references: Eur J Neurol. 2008 Apr;15 Suppl 1:1-4
references: 18353130
references: J Neurol. 2000 Apr;247 Suppl 2:II3-10
references: 10991663
references: CNS Neurol Disord Drug Targets. 2008 Jun;7(3):305-12
references: 18673214
references: Int J Neurosci. 1992 Jul-Aug;65(1-4):199-207
references: 1341683
references: Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8968-73
references: 12084935
references: Ann N Y Acad Sci. 2008 Oct;1139:331-6
references: 18991878
references: Arch Neurol. 2008 Sep;65(9):1191-4
references: 18779422
references: Brain Res. 1994 Dec 30;668(1-2):261-5
references: 7704612
references: J Neurol. 1998 Oct;245(10):659-64
references: 9776465
references: Acta Neuropathol. 1997 Sep;94(3):287-9
references: 9292699
references: PLoS One. 2011 Feb 25;6(2):e17269
references: 21364887
references: J Neurosci. 2009 Jun 24;29(25):8103-13
references: 19553450
references: J Neurosurg. 1988 Jun;68(6):955-9
references: 3131497
references: J Neurosci. 2006 Jan 4;26(1):41-50
references: 16399671
references: PLoS One. 2009 Aug 14;4(8):e6629
references: 19680561
references: Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S6-12
references: 20083010
references: Brain Struct Funct. 2008 Sep;213(1-2):197-213
references: 18663473
references: Neuropathol Appl Neurobiol. 2006 Jun;32(3):284-95
references: 16640647
references: Anal Bioanal Chem. 2005 Sep;383(2):224-34
references: 16132122
references: Adv Neurol. 1987;45:35-43
references: 3030070
references: Exp Neurol. 2009 Jun;217(2):269-81
references: 19268664
references: Neurodegener Dis. 2008;5(3-4):114-7
references: 18322366
references: Acta Pharmacol Toxicol (Copenh). 1985 Aug;57(2):130-5
references: 3877403
references: Brain Res. 2010 Jan 15;1310:189-99
references: 19896932
references: Ann Neurol. 2006 Apr;59(4):591-6
references: 16566021
references: Acta Neuropathol. 2008 Jul;116(1):125-8; author reply 129-31
references: 18446352
references: Neurodegener Dis. 2005;2(1):44-8
references: 16909002
references: Exp Neurol. 1993 Apr;120(2):223-32
references: 8491280
references: J Neural Transm Suppl. 1995;46:15-31
references: 8821039
references: J Neurosci. 2004 Oct 27;24(43):9553-60
references: 15509742
references: Clin Neuropharmacol. 1990 Apr;13(2):171-4
references: 2328508
references: J Neurol Neurosurg Psychiatry. 1989 Jun;52(6):701-8
references: 2545826
references: Neurosci Lett. 2008 Apr 11;435(1):24-9
references: 18314273
references: J Neurochem. 2008 Nov;107(3):745-55
references: 18761715
references: Brain Res Bull. 2009 Feb 16;78(2-3):91-6
references: 19007866
references: Brain Res. 1985 Dec 9;358(1-2):137-43
references: 3878182
references: Neuroscience. 2000;95(1):119-26
references: 10619468
references: Neurology. 2008 May 13;70(20):1916-25
references: 18474848
references: Brain Res. 2004 May 1;1006(2):150-6
references: 15051518
references: Brain Res Bull. 2009 Feb 16;78(2-3):80-4
references: 18790021
references: Exp Neurol. 1999 Jul;158(1):63-75
references: 10448418
references: Eur J Neurosci. 2003 Jun;17(12):2586-92
references: 12823465
references: Neuroscience. 2009 Feb 18;158(4):1478-87
references: 19118601
references: J Neurosurg. 1996 Mar;84(3):487-93
references: 8609563
references: Neuroscience. 2007 May 11;146(2):741-55
references: 17367952
references: J Neural Transm Suppl. 1999;56:1-29
references: 10370901
references: Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
references: 12498954
references: Arch Neurol. 2009 Feb;66(2):167-72
references: 19204152
references: Life Sci. 2007 Apr 24;80(20):1906-14
references: 17382353
references: Acta Neuropathol. 2006 Dec;112(6):681-9
references: 16957925
references: Eur J Neurosci. 2007 Oct;26(7):1925-39
references: 17897398
references: Arch Neurol. 2009 Jul;66(7):914-5; author reply 915-6
references: 19597100
references: Neurosci Lett. 2009 Jan 30;450(2):92-6
references: 19056464
references: J Neural Transplant Plast. 1993 Oct-Dec;4(4):289-97
references: 7948179
references: Mov Disord. 1989;4(1):53-74
references: 2494438
references: Mol Brain. 2010 Apr 21;3:12
references: 20409326
references: Behav Brain Res. 2005 Jul 30;162(2):222-32
references: 15970217
references: Brain Res. 1986 Nov 12;397(2):372-6
references: 2879605
references: Brain Pathol. 2003 Jul;13(3):364-72
references: 12946025
references: J Neurosci. 2003 Nov 26;23(34):10756-64
references: 14645467
references: Brain Res. 1993 May 28;612(1-2):319-21
references: 8101134
references: Parkinsons Dis. 2011 Feb 21;2011:124165
references: 21403896
references: Ann N Y Acad Sci. 2006 Aug;1074:349-56
references: 17105932
references: Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S26-30
references: 20083001
references: Int J Neuropsychopharmacol. 2011 Mar;14(2):187-200
references: 20426885
references: Neurobiol Aging. 2010 Dec;31(12):2103-14
references: 19152986
references: Arch Neurol. 1989 Jun;46(6):651-7
references: 2730377
references: Neurotox Res. 2009 Aug;16(2):127-39
references: 19526289
references: Lancet Neurol. 2009 Dec;8(12):1150-7
references: 19909913
references: Neurosci Bull. 2009 Feb;25(1):15-20
references: 19190684
references: Neuroscience. 1991;41(2-3):507-23
references: 1870701
references: Nervenarzt. 2000 Jun;71(6):459-69
references: 10919140
references: J Neurochem. 2003 Feb;84(3):491-502
references: 12558969
references: Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13804-9
references: 17702867
references: J Neurosurg. 1990 Jan;72(1):91-5
references: 2294192
references: Neuropathology. 2008 Feb;28(1):74-80
references: 18031467
references: Science. 2009 Mar 20;323(5921):1578-82
references: 19299613
references: Mov Disord. 2008 Mar 15;23(4):607-10
references: 18163454
references: Brain Res. 2009 Apr 10;1265:196-204
references: 19236855
references: Brain. 2000 Sep;123 ( Pt 9):1767-83
references: 10960043
references: J Chem Neuroanat. 2011 Mar;41(2):97-110
references: 21172422
references: Neurochem Res. 2009 Dec;34(12):2147-53
references: 19495971
references: J Pineal Res. 2008 Mar;44(2):205-13
references: 18289173
references: Neurology. 1993 May;43(5):986-91
references: 8492957
references: Neurobiol Aging. 2007 Sep;28(9):1421-35
references: 16872721
references: Zhonghua Bing Li Xue Za Zhi. 1998 Apr;27(2):113-6
references: 11244960
references: Neuropathol Appl Neurobiol. 1989 Jan-Feb;15(1):27-44
references: 2542825
references: Neurosci Lett. 1986 Apr 24;65(3):321-5
references: 3487052
references: J Neurochem. 2008 Mar;104(5):1309-20
references: 18036149
references: Mov Disord. 2002 Sep;17(5):917-27
references: 12360540
references: J Neurochem. 2004 Aug;90(3):654-8
references: 15255943
references: J Neurol Sci. 1979 Jul;42(2):187-97
references: 479910
references: Brain. 2007 Jan;130(Pt 1):265-75
references: 17148469
references: Ann N Y Acad Sci. 2002 Jun;965:274-80
references: 12105103
references: Mov Disord. 2009;24 Suppl 2:S671-6
references: 19877235
references: Synapse. 1999 Sep 15;33(4):282-8
references: 10421709
references: Exp Neurol. 2004 Jul;188(1):65-73
references: 15191803
references: J Neural Transm (Vienna). 2004 Feb;111(2):201-16
references: 14767723
references: J Neurosci Res. 1995 Jul 1;41(4):471-80
references: 7473878
references: Ann N Y Acad Sci. 2000 Sep;914:275-83
references: 11085327
references: Neurotox Res. 2009 Apr;15(3):246-51
references: 19384597
references: J Neural Transm (Vienna). 2008 May;115(5):731-5
references: 18196202
references: Expert Rev Neurother. 2009 Jun;9(6):847-57
references: 19496688
references: Behav Brain Res. 2004 Oct 5;154(2):353-63
references: 15313023
references: Sheng Li Xue Bao. 2007 Feb 25;59(1):79-85
references: 17294046
references: Mov Disord. 2005 Nov;20(11):1515-20
references: 16035099
references: Neuroscience. 2007 Jul 29;147(4):1047-58
references: 17611037
references: J Neurol. 2009 Aug;256 Suppl 3:270-9
references: 19711116
references: Brain Res. 2010 Apr 9;1324:64-74
references: 20153300
references: Nervenarzt. 2008 Feb;79(2):175-84
references: 17701389
references: Eur J Neurosci. 2010 Oct;32(7):1100-8
references: 21039949
references: Neurology. 2006 Apr 11;66(7):1100-2
references: 16606927
references: Eur J Neurosci. 2005 Dec;22(11):2765-74
references: 16324110
references: Acta Neuropathol. 2007 Apr;113(4):421-9
references: 17294202
references: Gene. 2011 Jul 15;481(1):7-16
references: 21440609
references: Parkinsons Dis. 2010 Jul 08;2010:375462
references: 20976083
references: J Chem Neuroanat. 2011 Dec;42(4):327-40
references: 21392570
references: J Neurosci. 2010 Jul 21;30(29):9919-28
references: 20660274
references: Acta Neurochir (Wien). 1995;133(1-2):61-7
references: 8561039
references: Brain Res. 2007 Feb 2;1131(1):211-9
references: 17173870
references: Neuroscience. 2009 Jun 2;160(4):796-804
references: 19272424
references: Ann Neurol. 1986 Oct;20(4):449-55
references: 3024555
references: Exp Brain Res. 2006 Aug;173(2):196-204
references: 16639500
references: J Neural Transm Suppl. 2004;(68):53-60
references: 15354389
references: J Clin Invest. 2002 Nov;110(10):1429-39
references: 12438441
references: Arch Neurol. 2003 Mar;60(3):337-41
references: 12633144
references: Psychopharmacology (Berl). 2008 Aug;199(3):303-12
references: 17899020
references: Acta Neuropathol. 2008 Apr;115(4):385-98
references: 18273623
references: J Neural Transm (Vienna). 1996;103(4):455-90
references: 9617789
references: Mov Disord. 1986;1(2):129-34
references: 3143064